Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference
Artivion, Inc. (NYSE: AORT) announced its participation in the 21st Annual Needham Virtual Healthcare Conference on April 14, 2022, at 9:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Artivion, Inc. (NYSE: AORT) announced its participation in the 21st Annual Needham Virtual Healthcare Conference on April 14, 2022, at 9:30 a.m. ET. The virtual fireside chat will be accessible via Artivion's website, with an archived version available for 90 days. Artivion focuses on innovative solutions for cardiac and vascular surgery, specifically targeting aortic diseases. Its product range includes aortic stents, surgical sealants, mechanical heart valves, and human tissues, sold in over 100 countries globally.
Details
News Market Reaction – AORT
The recorded move for AORT in the trading session of this news was -0.51%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTA, March 31, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming 21st Annual Needham Virtual Healthcare Conference. The Company's virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Thursday, April 14, 2022.
A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
Artivion | Gilmartin Group LLC |
D. Ashley Lee | Brian Johnston / Lynn Lewis |
Executive Vice President & | Phone: 332-895-3222 |
Chief Financial Officer | |
Phone: 770-419-3355 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-21st-annual-needham-virtual-healthcare-conference-301514629.html
SOURCE Artivion, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.